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en this time of health care reform debate in the U.S., it is
ashionable to focus on what is wrong. Unmentioned is
rguably the most important health triumph in the past 50
ears: the steep decrease in deaths from cardiovascular disease
1–3). Between 1950 and 2005, the age-adjusted, all-age death
ate from heart disease decreased from 587 per 100,000 persons
o 211 per 100,000, a spectacular improvement (4). As often
appens with such remarkable successes, the credit gets shared.
ne factor with a major claim to causality is the decrease in
moking prevalence as the result of strong tobacco-control
rograms (5,6).
See page 1249
In that regard, Goldman (2) estimates that 25% of the
ecrease in deaths from cardiovascular disease is from de-
reased disease incidence and 75% is from reducing deaths in
ersons with known disease. Of that 75% decrease, approxi-
ately one-half is due to risk factor reduction. Obviously,
moking figures in both primary prevention (decreased disease
ncidence) and secondary prevention (risk factor reduction).
ndeed, the decrease in smoking prevalence is another modern
ealth triumph. The prevalence of smoking among men in the
.S. has decreased from 57% in 1955 to 21% in 2007, whereas
moking among women declined from a high of 34% in 1965
o 18% in 2007 (5). The 2007 overall smoking prevalence rate
f 19.8% marked a modern low (7).
There are 2 routes whereby tobacco smoke can hurt a
atient’s heart—by smoking directly or by inhaling some-
ne else’s smoke. When smoking rates were high, it was
ard to avoid secondhand smoke, and it was also unclear
hat secondhand smoke was damaging because the assumption
as that—as with smoking and lung cancer—sustained expo-
ure was required for harm. But now that smoking is less
ommon and smokers are increasingly marginalized (8,9),
vidence has emerged that secondhand smoke exposure is
early as harmful to the heart as is chronic active smoking.
arnoya and Glantz (10) recently reviewed the many ways in
hich this harm occurs. Secondhand smoke exposure alters
latelet function, causes endothelial dysfunction, increases
rterial stiffness, decreases levels of high-density lipoprotein,
ncreases markers of inflammation, increases arterial intima-
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Department of Medicine, University of California San Francisco, SanH
rancisco, California. Dr. Schroeder is supported by grants from the Robert Wood
ohnson and American Legacy Foundations.edia thickening, increases infarct size, causes oxidative stress
nd mitochondrial damage, decreases heart rate variability
thus increasing the risk of malignant arrhythmias), and in-
reases insulin resistance (10). It is hard to imagine substances
hat would be more cardiotoxic. Furthermore, these adverse
ffects are observed at very low exposure doses (11).
So, what can cardiologists do to keep their patients from
eing exposed to tobacco smoke? Obviously, they should
ounsel patients who smoke to quit by serving as a resource
o help that happen; directing them to affiliated cessation
ystems such as those of Kaiser Permanente, Group Health
ooperative, the Mayo Clinic, or the Veterans Administra-
ion system; or referring them to toll-free telephone coun-
eling available through 1-800-QUIT NOW (12,13). How-
ver, cardiologists now must also attend to the risks of
econdhand smoke exposure.
This issue of the Journal contains a meta-analysis by
yers et al. (14) of published studies that examine changes
n rates of acute myocardial infarction (AMI) after the insti-
ution of second-hand smoke bans in specific locales. The
eview takes advantage of natural experiments in which public
moking was banned, and rates of AMI were compared before
nd after that ban, sometimes including comparison sites
ithout a ban. The inclusion criteria restricted the analysis to
nly 11 peer-reviewed articles representing 10 sites: 5 from the
.S., 1 from Canada, 3 from Italy, and 1 from Scotland.
bservation times for measuring the effect ranged from as
hort as 2 months to as long as 3 years. The populations
overed in the studies varied from a high of 19 million people
New York State) to a low of 29,000 (Bowling Green, Ohio).
n the meta-analysis, overall results were weighted by the
opulation size included in each study, as well as the duration
f observation after the ban was imposed.
The overall mean decrease in AMI incidence after ban
mposition was 17%. All studies showed at least 1 subgroup
ith decreases, and 9 had overall substantial declines, ranging
rom 9% to 50%. Two sites, both in Italy, had essentially
o change. Differences were greater in sites from the U.S. and
n those with longer observation periods, with AMI incidence
ecreasing by 26% with each year of post-ban observation. As
hown in the authors’ Figure 3, the longer the observation
eriod after the ban, the lower the incidence rates.
Why is this article important? First, by adding published
eports outside of the U.S., it builds on evidence of a
revious meta-analysis that showed a decrease in post-ban
MI incidence of 19% (15). When the first observation of the
ffect of smoking bans on community disease incidence in
elena, Montana, was reported, it was unclear whether this
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September 29, 2009:1256–7 Public Smoking Bans Are Good for the Heartelationship was an artifact or real, especially because the
omparison site had a large (46%) increase in AMI frequency
16). To some, those results seemed too good to be true. By
ombining all of the published studies on the effects of such
ans, Myers et al. (14) add to the evidence that these bans do
rotect the hearts of those prone to coronary disease. Further,
n the 5 reports that used nonban comparison sites, the nonban
ites all had much smaller decreases in AMI prevalence.
inally, the findings that the effect is stronger the longer the
eriod of observation and that the largest declines occurred in
he U.S.—where smoking prevalence is lower and thus the
roportion of nonsmokers who could be exposed to second-
and smoke is greater—support the hypothesis that smoking
ans are beneficial. As the authors note, the smaller effect sizes
ll occurred in studies outside the U.S. plus the New York
tate study. All these sites had short observation periods.
What are the limitations of this study? Publication bias is
lways a potential problem, although the authors were unable
o surface any reports that went unpublished. More problem-
tic is the reality that in the3,000 communities and 33 states
hat restrict public smoking in the U.S. (17), most have not
racked changes in AMI incidence. The same holds for other
ountries. Another potential limitation is the vigor with which
uch bans are enforced. Given the lower smoking prevalence
ates in the U.S. and the stigma attached to smoking in that
ountry, it is likely that such bans are more easily accepted
here and better enforced than in Italy and Scotland, where the
ublished reports showed either a lower (Italy) or average
Scotland) effect of smoking bans. A related question is
hether these decreases merely reflect the secular trends of
ecreasing AMI frequency. However, the rate of decrease is
uch greater than those secular trends, and those studies with
omparison sites all showed lower rates of decline, or in the
ase of Helena, a 46% increase.
Could there have been a coding effect, whereby the
iagnosis of AMI somehow changed in communities with
ans? That seems unlikely. More troubling is the fact that
he effects are much smaller in the reports from large
opulation sites, with the exception of Scotland. The
uthors tested whether geographic region (U.S. vs. non-
.S.), population size, or length of post-ban observation
eriod affected the incidence reduction rate and concluded
hat region and observation period did but size did not.
ow robust that conclusion is remains to be seen. It is likely
hat the larger the population encompassed by a ban, the
ess uniform enforcement of the ban might be.
The take-away messages for cardiologists are clear. A 17%
isk reduction for AMI is not trivial. It is prudent to assume
hat exposure to secondhand smoke is almost as dangerous to
ersons with diagnosed or latent coronary disease as active
moking (10). Therefore, cardiologists should expand their
linical repertoire to include screening and counseling for
econdhand smoke exposure, just as they screen for lipid
isorders. In their roles as health advocates, they should also
upport bans on public smoking, as well as other tobacco
ontrol measures such as tax increases on cigarettes, counter-
arketing campaigns, and expanded cessation services such aselephone quitlines (6,18,19). These initiatives lower the prob- sbility of young people initiating smoking, increase the rate at
hich smokers quit, and lower the frequency of smoking
mong those not yet willing or able to quit. Cardiologists not
nly have much to celebrate about the spectacular decreases in
ardiovascular disease, they also have the opportunity to do
uch more. Further decreased exposure to tobacco smoke,
uch as occurs with public smoking bans, is a keystone to such
rogress.
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